Final data from the German AHEAD study: effectiveness and safety of octocog alfa and rurioctocog alfa pegol for hemophilia A in a real-world setting.
Saved in:
| Title: | Final data from the German AHEAD study: effectiveness and safety of octocog alfa and rurioctocog alfa pegol for hemophilia A in a real-world setting. |
|---|---|
| Authors: | Klamroth R; Department for Internal Medicine, Vascular Medicine and Haemostaseology, Vivantes Klinikum im Friedrichshain, Landsberger Allee 49, 10249 Berlin, Germany.; Institute for Experimental Hematology and Transfusion Medicine, Bonn University Clinic, Bonn, Germany., Kurnik K; Department of Pediatrics, Pediatric Haemophilia Center, Dr. von Hauner Children's Hospital, LMU University Hospital Munich, Munich, Germany., Wenning S; SRH Kurpfalzkrankenhaus, Heidelberg, Germany., Escuriola-Ettingshausen C; Hämophilie-Zentrum Rhein Main GmbH, Frankfurt/Main, Germany., Regensburger S; Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany., Tang L; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Gu J; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Guerra R; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Oldenburg J; Institute for Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Bonn, Germany. |
| Source: | Therapeutic advances in hematology [Ther Adv Hematol] 2026 May 03; Vol. 17, pp. 20406207261419337. Date of Electronic Publication: 2026 May 03 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2040-6207 |
|---|---|
| DOI: | 10.1177/20406207261419337 |
